Elevation of cytokeratin 19 fragment in patients with interstitial pneumonia associated with polymyositis/dermatomyositis

Journal of Rheumatology

Volumn 26, Issue 11, 1999, Pages 2377-2382

  Fujita, Jiro ^a   Dobashi, Naomi ^b   Tokuda, Michiaki ^b   Bandoh, Shuji ^b   Ohtsuki, Yuji ^b   Yamadori, Ichiro ^b   Yoshinouchi, Takeo ^b   Ueda, Yutaka ^b   Takahara, Jiro ^b  

^a KAGAWA UNIVERSITY   (Japan)

^b NONE

Author keywords

Cytokeratin 19 fragment; Hyaline membrane; Interstitial pneumonia; Polymyositis dermatomyositis

Indexed keywords

CYCLOPHOSPHAMIDE; CYCLOSPORIN; CYTOKERATIN; CYTOKERATIN 19; IMMUNOSUPPRESSIVE AGENT; STEROID;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONNECTIVE TISSUE DISEASE; CONTROLLED STUDY; DERMATOMYOSITIS; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; HUMAN; HUMAN TISSUE; INTERSTITIAL PNEUMONIA; LUNG DISEASE; MALE; POLYMYOSITIS; PRIORITY JOURNAL; SERUM;

EID: 0032732068     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Mills ES, Matthews WH. Interstitial pneumonitis in dermatomyositis. JAMA 1956;160:1467-70.
2. Tazelaar HD, Viggiano RW, Pickersgill J, Colby TV. Interstitial lung disease in polymyositis and dermatomyositis: clinical features and prognosis as correlated with histologic findings. Am Rev Respir Dis 1990;141:727-33.
3. Katzenstein A, Fiorelli RF. Nonspecific interstitial pneumonia/fibrosis. Histologic features and clinical significance. Am J Surg Pathol 1994;18:136-47.
4. Moll R, Franke WW, Schiller DL. The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells. Cell 1982;31:11-24.
5. Fuchs E Keratins as biochemical markers of epithelial differentiation. Trends Genet 1988;4:277-81.
6. Coulombe PA. The cellular biology of keratins: beginning a new era. Curr Opin Cell Biol 1993;5:17-29.
7. Steinert PM. Structure, function, and dynamics of keratin intermediate filaments. J Invest Dermatol 1993;100:729-34.
8. Pujol JL, Grenier J, Daures J-P, Daver A, Pujol H, Michel FB. Serum fragment of cytokeratin subunit 19 measured by CYFRA 21-1 immunoradiometric assay as a marker of lung cancer. Cancer Res 1993;53:61-6.
9. Muraki M, Tohda Y, Iwanaga T, Uejima H, Nagasaka Y, Nakajima S. Assessment of serum CYFRA 21-1 in lung cancer. Cancer 1996;77:1274-7.
10. Lai RS, Hsu HK, Lu JY, Ger LP, Lai NS. CYFRA 21-1 enzyme-linked immunosorbent assay. Evaluation as a tumor marker in non-small cell lung cancer. Chest 1996;109:995-1000.
11. Pujol JL, Grenier J, Parrat E, et al. Cytokeratins as serum markers in lung cancer: a comparison of CYFRA 21-1 and TPS. Am J Respir Crit Care Med 1996;154:725-33.
12. Nakamura H, Abe S, Shibata Y, et al. Elevated levels of cytokeratin 19 in the bronchoalveolar lavage fluid in patients with chronic airway inflammatory disease - a specific marker for bronchial epithelial injury. Am J Respir Crit Care Med 1997;155:1217-21.
13. Bohan A, Peter JB. Polymyositis and dermatomyositis. I. N Engl J Med 1975;292:344-7.
14. Katzenstein ALA, Myers JL, Mazur MT. Acute interstitial pneumonia: a clinicopathologic, ultrastructural, and cell kinetic study. Am J Surg Pathol 1986;10:256-67.
15. Frazer AR, Miller RD. Interstitial pneumonitis in association with polymyositis and dermatomyositis. Chest 1974;65:403-7.
16. Schwartz MI. Pulmonary and cardiac manifestations of polymyositis-dermatomyositis. J Thorac Imaging 1992;7:46-54.
17. Salmeron G, Greenberg SD, Lidsky MD. Polymyositis and diffuse interstitial lung disease: a review of the pulmonary histopathological findings. Arch Intern Med 1981;141:1005-10.
18. Songcharoen S, Raju SF, Pennebaker JB. Interstitial lung disease in polymyositis and dermatomyositis. J Rheumatol 1980;7:353-60.
19. Dickey BF, Myers AR. Pulmonary disease in polymyositis/ dermatomyositis. Semin Arthritis Rheum 1984;14:60-76.
20. Iyonaga K, Miyafuji M, Suga M, Saita N, Ando M. Alterations in cytokeratin expression by the alveolar lining epithelial cells in lung tissue from patients with idiopathic pulmonary fibrosis. J Pathol 1997;182:217-24.